CNTNAP2 and encephalitis: The response to RTX is variable and in most of these disorders, a considerable number of patients exhibit a favorable response (like DPPX encephalitis, LGI1, caspr2 encephalitis), whereas in some the response is less profound (like in IgLON5) (115–117).